A. Brothers

A Phase I Study of an Agonist CD40 Monoclonal Antibody (CP-870,893) in Combination with Gemcitabine in Patients with Advanced Pancreatic Ductal Adenocarcinoma

A. Alavi, D. Torigian, A. Troxel, 2013, Clinical Cancer Research.

Allocation of scarce resources in a pandemic: rapid systematic review update of strategies for policymakers

Jeanne S. Ringel, J. Ringel, S. Hempel, 2021, Journal of Clinical Epidemiology.

Sexual Activity After Total Hip Arthroplasty: A Systematic Review of the Outcomes.

Michael A Mont, K. Issa, T. Pierce, 2017, The Journal of arthroplasty.

Cervical corpectomy with ultra-low-dose rhBMP-2 in high-risk patients: 5-year outcomes.

Michael A Mont, K. Issa, A. Brothers, 2013, Orthopedics.

Quantification of aging effects upon global knee inflammation by 18F-FDG-PET

S. Houshmand, T. Werner, A. Alavi, 2015, Nuclear medicine communications.

FDG PET/CT in Crohn’s disease: correlation of quantitative FDG PET/CT parameters with clinical and endoscopic surrogate markers of disease activity

A. Salavati, A. Alavi, D. Torigian, 2014, European Journal of Nuclear Medicine and Molecular Imaging.

Evolving role of FDG PET imaging in assessing joint disorders: a systematic review

Drew A. Torigian, Abass Alavi, Babak Saboury, 2011, European Journal of Nuclear Medicine and Molecular Imaging.

A Phase I Study of an Agonist CD40 Monoclonal Antibody (CP-870,893) in Combination with Gemcitabine in Patients with Advanced Pancreatic Ductal Adenocarcinoma

A. Alavi, D. Torigian, A. Troxel, 2013, Clinical Cancer Research.